Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis-Reference-Cited by-同舟云学术

Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis

Published:2020-01-01 Issue:1 Volume:25 Page:320-320
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Olivares Gazca Juan Carlos¹^ORCID,Gómez Almaguer David²,Gale Robert Peter³,Ruiz Argüelles Guillermo José¹^ORCID

Affiliation:

1. Centro de Hematología y Medicina Interna de Puebla, Puebla, Mexico

2. Department of Haematology, Hospital Universitario de Nuevo León, Monterrey, Mexico

3. Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2020.1802931

Reference7 articles.

1. American Society for Transplantation and Cellular Therapy (ASTCT). Interim guidelines for Covid-19 management in hematopoietic cell transplant and cellular therapy patients. [cited 2020 May 8]. Available from: https://higherlogicdownload.s3-external-1.amazonaws.com/ASBMT/COVID-19%20Interim%20Patient%20Guidelines%203_18_20.pdf?AWSAccessKeyId=AKIAVRDO7IEREB57R7MT&Expires=1588981435&Signature=1v9ELbK04CP0d%2BI%2Fq96GV9uPdTg%3D.

2. European Bone and Marrow Transplantation (EBMT). Coronavirus disease: EBMT recommendations [update 2020 Mar 23

3. cited 2020 May 8]. Available from: https://www.ebmt.org/sites/default/files/2020-03/EBMT%20COVID-19%20guidelines%20v.4.3%20%282020-03-23%29.pdf.

4. How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?

5. Perspective: SARS-CoV-2, COVID-19 and Haematologists

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2-infection in the setting of autotransplants for multiple sclerosis;Hematology;2023-01-10

2. Trasplante de células progenitoras hematopoyéticas (TCPH)en la era del COVID-19;Gaceta de M�xico;2022-01-06

3. Outpatient allogeneic hematopoietic stem-cell transplantation: a review;Therapeutic Advances in Hematology;2022-01

4. Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis;Multiple Sclerosis and Related Disorders;2022-01

5. COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review;Multiple Sclerosis and Related Disorders;2021-05